A detailed history of Vision Point Advisory Group, LLC transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Vision Point Advisory Group, LLC holds 24,554 shares of XBI stock, worth $2.2 Million. This represents 0.88% of its overall portfolio holdings.

Number of Shares
24,554
Previous 22,773 7.82%
Holding current value
$2.2 Million
Previous $2.11 Million 14.87%
% of portfolio
0.88%
Previous 0.79%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$90.87 - $102.43 $161,839 - $182,427
1,781 Added 7.82%
24,554 $2.43 Million
Q2 2024

Aug 01, 2024

BUY
$82.22 - $94.12 $685,139 - $784,301
8,333 Added 57.71%
22,773 $2.11 Million
Q1 2024

May 10, 2024

BUY
$87.05 - $102.89 $1.26 Million - $1.49 Million
14,440 New
14,440 $1.37 Million
Q2 2021

Aug 10, 2021

SELL
$122.48 - $139.69 $562,305 - $641,316
-4,591 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$129.36 - $173.99 $17,722 - $23,836
137 Added 3.08%
4,591 $623,000
Q4 2020

Feb 08, 2021

BUY
$110.36 - $151.14 $491,543 - $673,177
4,454 New
4,454 $627,000

Others Institutions Holding XBI

About SPDR SER TR SPDR S&P BIOTECH E


  • Ticker XBI
  • Sector ETFs
  • Industry ETFs
More about XBI
Track This Portfolio

Track Vision Point Advisory Group, LLC Portfolio

Follow Vision Point Advisory Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vision Point Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vision Point Advisory Group, LLC with notifications on news.